Italy’s cataract surgery devices market has matured from a largely hospital-centric sector into one of the most dynamic pockets of the Italian medtech landscape, driven by decades-long clinical evolution and by a rapidly ageing population that places Italy among Europe’s highest-volume cataract treatment nations. Historically, the shift began in the 1980s–1990s with phacoemulsification becoming standard and intraocular lens (IOL) implantation commonplace; in the last 15 years those clinical gains have been amplified by the arrival of premium IOLs and femtosecond laser platforms that raise procedure value and patient expectations. Marketing and promotion in this therapeutic area must navigate stringent national and EU rules, under EU law the MDR (Regulation (EU) 2017/745) governs device conformity and post-market surveillance, and Italy implemented national legislative decrees to align domestic law with the MDR; manufacturers must register devices in the Ministry of Health database (RDM) to supply hospitals, and non-EU manufacturers are required to appoint an EU Authorized Representative. Those device-registration and reporting obligations materially affect time-to-market and the information marketers can publish. In addition, Italy has recently tightened the regulatory framework for advertising medical devices, meaning promotional materials aimed at the public or HCPs increasingly require careful legal sign-off and, in many cases, explicit ministerial authorization before release, a practical constraint that forces marketers to build compliant, evidence-based communications and to invest in medical-legal review workflows.According to the research report " Italy Cataract Surgery Devices Market Research Report, 2030," published by Actual Market Research, the Italy Cataract Surgery Devices market is expected to reach a market size of USD 280 Million by 2030. Italy’s regionalized procurement systems create geographic variability in device adoption and pricing. For companies operating in Italy this means balancing regulatory compliance (MDR conformity, Italian registration), disciplined, medically credible marketing (following the Ministry’s advertising rules), and tailored commercial models (tenders and private clinic partnerships) to capture a market that is simultaneously large, clinically progressive, and tightly governed.

The transition from traditional cataract removal to laser-assisted and micro-incision techniques has revolutionized surgical precision and outcomes. Femtosecond laser platforms, improved fluidics in phacoemulsification consoles, and AI-assisted diagnostic tools have significantly enhanced the efficiency and safety of cataract procedures in Italy. These innovations not only increase surgeon confidence but also reduce postoperative complications, making the procedures more appealing to patients. Moreover, Italian hospitals and private clinics are investing heavily in digital imaging, advanced biometers, and 3D visualization systems that optimize lens selection and improve patient satisfaction. This ongoing modernization in ophthalmic care is helping Italy align with global surgical standards while supporting domestic growth in the medical devices industry. The Italian government ensures that all cataract surgery devices comply with stringent European Union Medical Device Regulation (MDR) standards.

This ensures product quality, clinical safety, and traceability, which boosts consumer confidence in the system.Intraocular lenses (IOLs) represent the largest share of the Italian cataract devices market, driven by a high prevalence of cataracts among aging citizens and a continuous increase in surgical volumes across both public and private healthcare facilities. While monofocal IOLs remain standard under Italy’s national healthcare system (Servizio Sanitario Nazionale - SSN), premium IOLs—including multifocal, toric, and extended depth-of-focus lenses—are witnessing strong growth within private clinics and self-paying segments, as patients seek enhanced visual quality and spectacle independence. Phacoemulsification systems are the dominant surgical technology in Italy, as they ensure minimally invasive, efficient, and safe cataract removal. Italian ophthalmic surgeons have widely adopted advanced phaco systems from major global manufacturers such as Alcon, Johnson & Johnson Vision, and Zeiss, emphasizing precise control, fluidics optimization, and shorter recovery periods. Ophthalmic viscoelastic devices (OVDs) continue to see steady demand, as they are indispensable for maintaining intraocular space and minimizing corneal damage during surgery. Meanwhile, femtosecond laser systems though limited by their high costs are gradually gaining traction in Italy’s private ophthalmic centers that focus on bladeless and customized cataract procedures.

The other category, including micro-surgical tools, knives, cannulas, and disposable consumables, remains vital in supporting Italy’s extensive cataract surgery network, particularly in regional hospitals and smaller clinics.Hospitals, particularly those operating under the national health system, account for the majority of cataract procedures, offering accessible treatments to elderly patients covered by public insurance. These hospitals are equipped with advanced phacoemulsification units and OVDs to ensure safe and standardized procedures. However, the Italian government’s healthcare reforms and focus on cost-efficiency have encouraged a steady shift toward ambulatory surgery centers (ASCs) and day-care ophthalmic units, which enable high patient turnover and reduced waiting times for cataract operations. ASCs are especially popular in urban regions such as Lombardy, Emilia-Romagna, and Lazio, where outpatient surgery models are well established. Ophthalmology clinics especially private practices and specialized vision centers have become major players in offering elective cataract procedures, premium IOL implants, and laser-assisted surgeries for patients seeking personalized and high-end care. These clinics often collaborate with multinational manufacturers to integrate the latest diagnostic and surgical innovations.

Academic and research institutes, including universities such as the University of Milan and the University of Rome “La Sapienza,” are deeply involved in ophthalmic training, clinical research, and trials for next-generation cataract technologies. Through collaboration with European and global medical organizations, these institutions advance surgical techniques and lens innovations.Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cataract Surgery Devices Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Intra-ocular Lenses (IOL)• Phacoemulsification Systems• Ophthalmic Viscoelastic Devices• Femtosecond Laser Systems• Others (Knives and Low-Cost Consumables)By End User• Hospitals• Ambulatory Surgery Centers• Ophthalmology Clinics• Academic and Research Institutes.